Maartje Verschuur

Senior Director CMC at AM-Pharma
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Leiden, South Holland, Netherlands, NL

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Netherlands
    • Biotechnology
    • 1 - 100 Employee
    • Senior Director CMC
      • Apr 2021 - Present

      Utrecht, Netherlands AM-Pharma strives to develop treatments for patients confronted with severe medical conditions. AM-Pharma’s lead product candidates are currently in early-stage clinical development. As Senior Director CMC I am responsible for clinical-stage and late-stage CMC development and manufacturing of drug substance and drug product. Specifically: ➢ Management of CMC development from early clinical stages through commercial launch ➢ Clinical drug substance and drug product… Show more AM-Pharma strives to develop treatments for patients confronted with severe medical conditions. AM-Pharma’s lead product candidates are currently in early-stage clinical development. As Senior Director CMC I am responsible for clinical-stage and late-stage CMC development and manufacturing of drug substance and drug product. Specifically: ➢ Management of CMC development from early clinical stages through commercial launch ➢ Clinical drug substance and drug product manufacturing planning and coordination ➢ Clinical supply management ➢ Contribute to the development of the commercial manufacturing strategy ➢ Lead the CDMO selection and -management ➢ Coordination with partners and stakeholders (e.g. CMC, regulatory, quality, clinical, commercial) ➢ Delivering CMC sections of regulatory submissions (e.g. IND/IMPD, BLA/MAA) Show less

    • United Kingdom
    • Research
    • 1 - 100 Employee
    • Senior Consultant CMC
      • Sep 2015 - Mar 2021

      Breda Area, Netherlands Strategic leadership and operational support in Chemistry Manufacturing and Controls (CMC) of biologics, from pre-clinical to Phase III and commercialization. Clients included biotech start-ups as well as global biopharma. Areas of expertise and responsibility: ➢ CMC project management and line management ➢ CDMO selection and outsource management ➢ Delivering CMC sections for regulatory documents including IMPD/ IND and MAA/BLA ➢ Subject matter expert upstream process… Show more Strategic leadership and operational support in Chemistry Manufacturing and Controls (CMC) of biologics, from pre-clinical to Phase III and commercialization. Clients included biotech start-ups as well as global biopharma. Areas of expertise and responsibility: ➢ CMC project management and line management ➢ CDMO selection and outsource management ➢ Delivering CMC sections for regulatory documents including IMPD/ IND and MAA/BLA ➢ Subject matter expert upstream process development ➢ Technical Due Diligence ➢ Developing drug development plans Show less

    • Netherlands
    • Biotechnology
    • 100 - 200 Employee
    • Project Manager CMC
      • Nov 2013 - Aug 2015

      Leiden, the Netherlands Program management of pre-clinical and Phase I/II customer programs; CMC development and (GMP) manufacturing of biologics.

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Senior group leader cell culture development
      • Apr 2011 - Sep 2013

      San Francisco Bay Area Leading CMC efforts for monoclonal antibodies and therapeutic proteins, through early- and late stages of development including tech transfer and scale- up for (commercial) manufacturing. Support of regulatory submissions. Line management responsibilities.

    • Manager upstream process development and Principal scientist
      • Aug 2008 - Apr 2011

      Weesp, the Netherlands Leading CMC development efforts for cell culture-based and egg-based Influenza vaccines. Annual update of the marketed Influenza vaccine(s) and manufacturing support. Support of regulatory submissions. Line management responsibilities.

    • Biotechnology Research
    • 1 - 100 Employee
    • Senior scientist
      • May 2004 - Jul 2008

      Leiden, the Netherlands As team lead responsible for the development of pre-clinical and Phase I/II upstream- and downstream production protocols for recombinant proteins and vaccines.

    • Netherlands
    • Research Services
    • 700 & Above Employee
    • PhD student
      • 1999 - 2004

Education

  • TIAS School for Business and Society
    Executive Leadership & Management Program
    2023 - 2024
  • Leiden University
    PhD, Molecular Biology and Cell Biology
    1999 - 2004
  • Wageningen University & Research
    MSc, Biotechnology
    1993 - 1999

Community

You need to have a working account to view this content. Click here to join now